{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:30:32Z","timestamp":1790767832926,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UL1TR001442"],"award-info":[{"award-number":["UL1TR001442"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A 7-day course of glecaprevir\/pibrentasvir started in the preoperative period prevented transmission of hepatitis C virus (HCV) from viremic donors to 10 HCV-negative recipients (2 heart, 1 lung, 6 kidney, 1 heart\/kidney) with 100% sustained virological response at 12 weeks.<\/jats:p>","DOI":"10.1093\/ofid\/ofac550","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T06:08:00Z","timestamp":1666850880000},"source":"Crossref","is-referenced-by-count":10,"title":["A Pilot Trial for Prevention of Hepatitis C Virus Transmission From Donor to Organ Transplant Recipient With Short-Course Glecaprevir\/Pibrentasvir"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-7827","authenticated-orcid":false,"given":"Claudia","family":"Ramirez-Sanchez","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Global Public Health, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Kozuch","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mita M","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Berumen","sequence":"additional","affiliation":[{"name":"Division of Transplant and Hepatobiliary Surgery, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Mekeel","sequence":"additional","affiliation":[{"name":"Division of Transplant and Hepatobiliary Surgery, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Schnickel","sequence":"additional","affiliation":[{"name":"Division of Transplant and Hepatobiliary Surgery, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Taremi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Global Public Health, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Golts","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Afshar","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-0188","authenticated-orcid":false,"given":"Eric","family":"Adler","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Pretorius","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Aslam","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Global Public Health, University of California San Diego , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"2022112209024663700_ofac550-B1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.healun.2019.08.019","article-title":"Outcomes of heart transplantation from hepatitis C virus-positive donors","volume":"38","author":"Aslam","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2022112209024663700_ofac550-B2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2468-1253(19)30240-7","article-title":"Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study","volume":"4","author":"Bethea","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2022112209024663700_ofac550-B3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.15162","article-title":"Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors","volume":"19","author":"Kwong","year":"2018","journal-title":"Am J Transplant"},{"key":"2022112209024663700_ofac550-B4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"2022112209024663700_ofac550-B5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cid\/cix798","article-title":"Cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings","volume":"66","author":"Assoumou","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2022112209024663700_ofac550-B6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13027-016-0071-z","article-title":"Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States","volume":"11","author":"Rosenthal","year":"2016","journal-title":"Infect Agents Cancer"},{"key":"2022112209024663700_ofac550-B7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.healun.2020.03.004","article-title":"Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: an ISHLT expert consensus statement","volume":"39","author":"Aslam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022112209024663700_ofac550-B8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ajt.15664","article-title":"Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients","volume":"20","author":"Gupta","year":"2019","journal-title":"Am J Transplant"},{"key":"2022112209024663700_ofac550-B9","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"2022112209024663700_ofac550-B10","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1111\/ajt.16747","article-title":"Outcomes of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants","volume":"21","author":"Gupta","year":"2021","journal-title":"Am J Transplant"},{"key":"2022112209024663700_ofac550-B11","article-title":"Recommendations for testing, managing, and treating hepatitis C","author":"AASLD-IDSA"},{"key":"2022112209024663700_ofac550-B12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/jcm11030770","article-title":"Transplantation of organs from hepatitis C virus-positive donors under direct-acting antiviral regimens","volume":"11","author":"Zahid","year":"2022","journal-title":"J Clin Med"},{"key":"2022112209024663700_ofac550-B13","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.healun.2020.01.998","article-title":"Successful transplantation of 96 hepatitis C-positive donor hearts in the era of direct-acting antiviral therapies","volume":"39","author":"Schlendorf","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022112209024663700_ofac550-B14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40472-021-00350-1","article-title":"Hepatitis C positive organ donation in heart transplantation","volume":"8","author":"Siddiqi","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"2022112209024663700_ofac550-B15","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1164\/rccm.201712-2614LE","article-title":"Lung transplantation from hepatitis C viremic donors to uninfected recipients","volume":"197","author":"Abdelbasit","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2022112209024663700_ofac550-B16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2468-1253(20)30081-9","article-title":"Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study","volume":"5","author":"Feld","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2022112209024663700_ofac550-B17","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.xphs.2018.02.015","article-title":"A phase 1 study to evaluate the effect of crushing, cutting into half, or grinding of glecaprevir\/pibrentasvir tablets on exposures in healthy subjects","volume":"107","author":"Oberoi","year":"2018","journal-title":"J Pharm Sci"},{"key":"2022112209024663700_ofac550-B18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2018.03.007","article-title":"High SVR12 with 8-week and 12-week glecaprevir\/pibrentasvir therapy: an integrated analysis of HCV genotype 1\u20136 patients without cirrhosis","volume":"69","author":"Puoti","year":"2018","journal-title":"J Hepatol"},{"key":"2022112209024663700_ofac550-B19","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2147\/DDDT.S172512","article-title":"Glecaprevir\/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy","volume":"13","author":"Cotter","year":"2019","journal-title":"Drug Des Devel Ther"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac550\/46650331\/ofac550.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/11\/ofac550\/47178080\/ofac550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/11\/ofac550\/47178080\/ofac550.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T09:03:25Z","timestamp":1669107805000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac550\/6775259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac550","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,10,27]]},"article-number":"ofac550"}}